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Abstract
Purpose: 7-ketocholesterol (7kCh), a natural byproduct of oxidation in lipoprotein
deposits is implicated in the pathogenesis of diabetic retinopathy and age-related
macular degeneration (AMD). This study was performed to investigate whether several
clinical drugs can inhibit 7kCh-induced caspase activation and mitigate its apoptotic
effects on retinal cells in vitro.
Method: Two populations of retinal cells, human retinal pigment epithelial cells (ARPE-19)
and rat neuroretinal cells (R28) were exposed to 7kCh in the presence of the following
inhibitors: Z-VAD-FMK (pan-caspase inhibitor), simvastatin, memantine, epicatechin, and
Z-IETD-FMK (caspase-8 inhibitor) or Z-ATAD-FMK (caspase-12 inhibitor). Caspase-3/7, -8,
and -12 activity levels were measured by fluorochrome caspase assays to quantify cell
death. IncuCyte live-cell microscopic images were obtained to quantify cell counts.
Results: Exposure to 7kCh for 24 hours significantly increased caspase activities for
both ARPE-19 and R28 cells (P < 0.05). In ARPE cells, pretreatment with various drugs
had significantly lower caspase-3/7, -8, and -12 activities, reported in % change in mean
signal intensity (msi): Z-VAD-FMK (48% decrease, P < 0.01), memantine (decreased 47.8%
at 1 µM, P = 0.0039 and 81.9% at 1 mM, P < 0.001), simvastatin (decreased 85.3% at 0.01
µM, P < 0.001 and 84.8% at 0.05 µM , P < 0.001) or epicatechin (83.6% decrease, P
< 0.05), Z-IETD-FMK (68.1% decrease, P < 0.01), and Z-ATAD-FMK (47.7% decrease, P =
0.0017). In contrast, R28 cells exposed to 7kCh continued to have elevated caspase-
3/7, -8, and -12 activities (between 25.7% decrease and 17.5% increase in msi, P > 0.05)
regardless of the pretreatment.
Conclusion: Several current drugs protect ARPE-19 cells but not R28 cells from 7kCh-
induced apoptosis, suggesting that a multiple-drug approach is needed to protect both
cells types in various retinal diseases.
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INTRODUCTION
Apoptosis is a highly regulated process of
programmed cell death critical in various disease
states and degenerations. These pathways
are implicated in various neurodegenerative
diseases (e.g., Alzheimer’s disease, Parkinson’s
disease, amyotrophic lateral sclerosis), ocular
diseases (e.g., glaucoma, diabetic retinopathy and
age-related macular degeneration [AMD]), and
immunologic disorders.[1–6] While treatments for
the wet form of AMD rely on inhibiting choroidal
neovascularization via anti-vascular endothelial
growth factor (anti-VEGF) injections,[7] there is
currently no cure for the dry form of AMD.
A pro-apoptotic oxysterol implicated in AMD
is 7-ketocholesterol (7kCh), a toxic metabolite
generated from the oxidation of cholesterol-esters
in low density lipoprotein (LDL), atheromatous
plaques, and drusen.[6, 8–10] 7kCh activates
three distinct kinase signaling pathways via
NFkB, MAPK, and ERK to upregulate pro-
inflammatory cytokines: IL-6, IL-8, and vascular
endothelial growth factor (VEGF) which induce
neovascularization in the choroid.[7, 8, 11–13] In
previous studies, retinal pigment epithelial (RPE)
cells and vascular endothelial cells had an 8- to
10-fold increase in VEGF levels,[14] and a 2-fold
increase in endothelial smooth muscle cells after
exposure to 7kCh.[15] Our previous studies showed
that in both ARPE-19 and rat neuroretinal R28
cell cultures, 7kCh significantly increased the
levels of pro-apoptotic caspase-3, -8, and -12
activities.[16–19] 7kCh is also a chemoattractant
that directs microglia to the outer retina to
produce metalloproteinases that cause breaks
in Bruch’s membrane and produce pro-angiogenic
substances.[11, 14, 20] A 2019 study showed that
7kCh intravitreally injected into rat retinas induced
apoptosis in photoreceptors and RPE cells
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and caused microvilli detachment in the outer
segment.[10] Thus, the toxic accumulation of 7kCh
over decades may activate cellular processes
that predispose patients to age-related ocular
pathologies such as AMD.[8]
Despite the strong evidence of 7kCh’s role in
age-related diseases, little is known about its
detoxifying mechanisms. A 2019 study showed
that compounds such as vitamin E, oleic acid,
terpenoids, and polyphenols inhibit 7kCh-induced
apoptosis,[21] while resveratrol, an antioxidant and
anti-inflammatory stilbenoid found in the skin
of grapes and red wine inhibits 7kCh-induced
VEGF expression.[22] Successful inhibition by these
natural compounds advances our knowledge
related to functional food therapies.[21]
Thus, it is necessary to explore the potential
drugs or inhibitors given the limited body
of knowledge on 7kCh detoxification. The
present study investigates six different inhibitors
(simvastatin [lipid lowering medication], memantine
[used to treat Alzheimer’s disease], epicatechin
[flavonoid present in green tea], Z-VAD-FMK
[pan-caspase inhibitor], Z-IETD-FMK [caspase-8
inhibitor], and Z-ATAD-FMK [caspase-12 inhibitor])
to identify drugs/agents that can block the 7kCh-
induced caspase activation. Our results show that
these drugs are effective in ARPE-19 cells but not
in R28 cells, implicating the need for a multidrug




R28 rat neurosensory cells have properties
that resemble those of various human
neurosensory cells. The R28 cells derived
from retina of post-natal day 6 rats were
cultured in Dulbecco’s modified Eagle’s media,
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10µg/mL gentamicin, 10mM non-essential amino
acids, and high glucose (DMEM high glucose;
Invitrogen-Gibco, Carlsbad, CA) with 10% fetal
bovine serum. Despite their clonal origin, R28
cells are characteristically heterogeneous, display
both glial and neuronal cell markers, and have
functional neuronal properties.[23] R28’s diversity
of cell types, ability to respond to a variety of
stimuli, and differentiation potential makes it an
appropriate model for neuroretinal tissue.[24]
A 1:1 mixture (vol/vol) of Dulbecco’s modified
Eagle’s and Ham’s nutrient mixture F-12 was used
to grow ARPE-19 cells (ATCC, Manassas, VA);
(Invitrogen-Gibco, Carlsbad, CA), 0.37% sodium
bicarbonate, 0.058% L-glutamine, 10% fetal bovine
serum, antibiotics (100U/ml penicillin G, 0.1mg/ml
streptomycin sulfate, 10µg/mL gentamicin), 10mM
non-essential amino acids, and an anti-fungal
agent (amphotericin-B 2.5µg/mL). ARPE-19 cells
are a homogeneous, retinal-derived cell line with
functional and structural properties similar to
human RPE cells.[25] All cells within the ARPE-
19 culture express RPE-specific markers such as
CRALBP, BEST1, and RPE-65.[26]
Cell Plating
Cells were plated on 24 well plates (Becton
Dickinson Labware, Franklin Lakes, NJ) at 150,000
cells per well and incubated at 37°C in 5% CO2
until confluent. Cell incubation was performed in a
serum-freemedia for 24 hours to prevent excessive
proliferation. Cells in the experimental group were
then pretreated with various inhibitors while the
cells in the control group were only exposed to
DMSO (the vehicle for 7kCh). All experimental cells
besides the control cells were then exposed to 30
µg/ml 7kCh for 24 hours before caspase activity
was assessed.
Caspase-3/7, -8, and -12 Detection
Carboxyfluorescein FLICA Caspase Apoptosis
Detection kits (Immunochemistry Technologies
LLC, Bloomington, MN) were used to quantify cells
undergoing caspase-mediated apoptosis. The
FLICA Detection Reagent contains a caspase
inhibitor sequence linked to a fluorescent
carboxyfluorescein probe with an optimal
excitation range of 488–492 nm and an emission
range of 515–535 nm. The probe only fluoresces
when the FLICA reagent covalently binds to
activated caspase-3/7 and -8 in vitro. The
fluorescence intensity quantifies the number of
whole, living cells undergoing caspase-mediated
apoptosis since cells with premature, inactivated,
or no caspase activity will not fluoresce. This was
measured using the Fluorescence Image Scanning
Unit (FMBIO III) instrument (Hitachi, Yokohama,
Japan).
Caspase-12 activity was detected using
CaspGLOW Fluorescein Caspase-12 staining
kit (BioVision). The assay utilizes the caspase-
12 inhibitor, Z-ATAD-FMK (Ala-Thr-Ala-Asp-
fluoromethylketone), conjugated to FITC (FITC-
ATAD-FMK) as a marker. FITC-ATAD-FMK
irreversibly binds to activated caspase-12 in
cells undergoing apoptosis and is cell permeable
and nontoxic.
Fresh culture media were used to rinse the wells
at 24 hours. Then, 300 µl/well of FLICA solution in
culture media were placed in the wells for 1 hour.
Phosphate buffered saline (PBS) was used to wash
the wells three times. The experimental groups
were (1) R28 and ARPE-19 cells with 30 µg/ml 7kCh
alone; (2) R28 and ARPE-19 cells with inhibitor; and
(3) R28 and ARPE-19 cells with DMSO. The different
inhibitors used were 1 µM and 1 mM memantine
(Alexis Biochemical, San Diego), 0.01 µM and
0.05 µM simvastatin (Merck and Co., Whitehouse
Station, NJ), 5 µM epicatechin (Sigma Aldrich
Inc, St Louis, MO), the pan-caspase inhibitor
Z-VAD-FMK (Val-Ala-Asp-fluoromethylketone,
Immunochemistry Technologies LLC, Bloomington,
MN), the caspase-8 inhibitor (Z-IETD-FMK, Iso-Glu-
Thr-Asp-fluoromethylketone, Calbiochem, La Jolla,
CA), and caspase-12 inhibitor (Z-ATAD-FMK, Ala-
Thr-Ala-Asp-fluoromethylketone, Calbiochem, La
Jolla, CA). The inhibitors were added to the culture
medium 1 hour before exposing cells to 7kCh.
In addition to the experimental groups, we
also analyzed the following control groups: (1)
untreated R28 cells and ARPE-19 cells without
FLICA or CaspGLOW to exclude autofluorescence
from cells; (2) untreated R28 and ARPE-19 cells with
FLICA or CaspGLOW for comparison of caspase
activity of treated cells; (3) tissue culture plate wells
(without cells) with buffer alone to represent the
background levels; (4) tissue culture plate wells
without cells with culture media and DMSO in order
to exclude cross-reaction of culture media and/or
DMSO with the plastic material of the tissue culture
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plate or cross-reaction of FLICA or CaspGLOW; (5)
R28 cells and ARPE-19 cells with DMSO and FLICA
to account for any cross-fluorescence due to the
cross-reaction of untreated cells with DMSO; and
(6) untreated R28 and ARPE-19 cells with negative
control Z-FA-FMK and FLICA as a control for the pan
caspase inhibitor.
IncuCyte® Live-Cell Imaging Analysis was used
to capture fluorescent images in real time. NucLight
Rapid Red and Caspase-3/7 Green reagents were
used to stain cells in 96-well plates at 5,000–
10,000 cells/well. The NucLight Rapid Red reagent
quantifies the amount of cell proliferation in
IncuCyte live-cell images by staining the nuclei
of living cells. The Caspase-3/7 Green reagent
contains an oligopeptide cleavage sequence
(DEVD) conjugated to a DNA-binding dye. The
green reagent labels apoptotic cells at an emission
maximum of 533 nm once the sequence is cleaved
by caspase-3/7. Images were captured per well
every 3 hours for five days with Brightfield, Red,
andGreen channels. Apoptosis due to caspase-3/7
activity is discriminated from live and necrotic cells
by overlapping the signal counts from NucLight
Red with the Caspase-3/7 green.
Statistical Analysis
ANOVAusingGraphPad Prism 3.0 version statistics
program (GraphPad Software Inc., San Diego,
CA) was used for statistical analysis of the data.
The data within each experiment were compared
using theNewman–Keulsmultiple comparison test.
Mean ± standard error of mean (SEM) was used
to present the data. Experiments were performed
in triplicate. P-values < 0.05 were considered
statistically significant.
RESULTS
Pan-caspase Inhibitor Z-VAD-FMK Reduces
Caspase-3/7 Activity in Only ARPE-19 Cells
ARPE-19 cells exposed to 7kCh had increased
caspase-3/7 activity (31,311 ± 766.7 msi, P <
0.0001) compared to the ARPE-19 cells exposed
only to DMSO (6,086 ± 910 msi, Figure 1A).
Caspase-3/7 activity in ARPE-19 cells decreased
significantly at 48.0% following pretreatment with
Z-VAD-FMK (16,278 ± 323.1 msi, P < 0.0001,
Figure 1A). R28 cells exposed to 7kCh had
increased caspase-3/7 activity (34,014 ± 2,126
msi, P = 0.0001) compared to the R28 cells
exposed only to DMSO (1,975 ± 234.5 msi,
Figure 1B). Caspase-3/7 activity in R28 cells
did not decrease significantly at 12.3% following
pretreatment with Z-VAD-FMK (29,805 ± 3,007
msi, P > 0.05, Figure 1B). The pan-caspase inhibitor
Z-VAD-FMK was not able to protect the R28
cells.
1 μM and 1 mM Memantine Reduce Caspase-
3/7 Activity in Only ARPE-19 Cells
ARPE-19 cells exposed to 7kCh had increased
caspase-3/7 activity (32,972 ± 1,891 msi, P =
0.001) compared to ARPE-19 cells exposed only to
DMSO (12,791 ± 1,501 msi, Figure 2A). Caspase-3/7
activity in ARPE-19 cells decreased significantly at
47.8% following pretreatment with 1 µM memantine
(17,218 ± 1,835 msi, P = 0.003, Figure 2A) and
even more so at 81.9% with 1 mM memantine
(5,969 ± 1,596 msi, P < 0.001, Figure 2A). R28
cells exposed to 7kCh had increased caspase-3/7
activity (31,974 ± 2,599 msi, P < 0.001) compared
to R28 cells exposed only to DMSO (2,355 ±
254.4 msi, Figure 2B). Caspase-3/7 activity in
R28 cells did not decrease significantly following
pretreatment with 1 µM memantine (33,850 ±
1,894 msi, P > 0.05, Figure 2B) nor with 1
mM memantine (33,422 ± 863.7 msi, P > 0.05,
Figure 2B). Neither concentration of the NMDA
inhibitor memantine protected the R28 cells from
apoptosis.
0.01 μM and 0.05 μM Simvastatin Reduce
Caspase-3/7 Activity in Only ARPE-19 Cells
ARPE-19 cells exposed to 7kCh had increased
caspase-3/7 activity (32,972 ± 1,891 msi, P = 0.001)
compared to ARPE-19 cells exposed only to DMSO
(12,791 ± 1,501 msi, Figure 2C). Caspase-3/7 activity
in ARPE-19 cells decreased significantly at 85.3%
following pretreatment with 0.01 µM simvastatin
(4,849 ± 500.2 msi, P < 0.001, Figure 2C) and at
84.8%with 0.05 µM simvastatin (5,016± 968.5msi,
P < 0.001, Figure 2C). R28 cells exposed to 7kCh
had increased caspase-3/7 activity (31,974 ± 2,599
msi, P < 0.001) compared to R28 cells exposed
only to DMSO (2,355 ± 254.4 msi, Figure 2D).
Caspase-3/7 activity in R28 cells did not decrease
significantly at 8.3% following pretreatment with
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Figure 1. Caspase-3/7 activity in 7kCh-treated ARPE-19 and R28 cells in response to 7kCh alone or pretreatment with Z-VAD-FMK.
Cells exposed to 7kCh alone increased caspase-3/7 activity*** (A–B). ARPE-19 cells pretreated with Z-VAD-FMK decreased
caspase-3/7 activity*** (A). In contrast, R28 cells pretreated with Z-VAD-FMK did not have decreased caspase-3/7 activity (B).
*P < 0.05, **P < 0.01, ***P < 0.001. The error bars represent the standard error of the mean (SEM) of measurements for the three
conditions in three separate runs (n = 9, A–B).
0.01 µM simvastatin (29,316 ± 897.9 msi, P >
0.05, Figure 2D) nor with 0.05 µM simvastatin,
which had a slight increase in activity at 17.5%
(37,575 ± 1,629 msi, P > 0.05, Figure 2D). Neither
concentration of simvastatin protected the R28
cells from apoptosis.
5 μM Epicatechin Reduces Caspase-3/7
Activity in Only ARPE-19 Cells
ARPE-19 cells exposed to 7kCh had increased
caspase-3/7 activity (32,181± 4,839 msi, P = 0.005,
Figure 2E) compared to ARPE-19 cells exposed
only to DMSO (5,936 ± 491.4 msi, Figure 2E).
Caspase-3/7 activity in ARPE-19 cells decreased
significantly at 83.6% following pretreatment with
5 µM epicatechin (5,263 ± 4,344 msi, P <
0.05, Figure 2E). R28 cells exposed to 7kCh
had increased caspase-3/7 activity (34,720 ±
3,197 msi, P < 0.001, Figure 2F) compared to
R28 cells exposed only to DMSO (2,488 ± 116.3
msi, Figure 2F). Caspase-3/7 activity in R28 cells
decreased at 25.7% following pretreatment with
5 µM epicatechin (25,806 ± 977.5 msi, P = 0.05,
Figure 2F), but the p-value was not significant.
Representative IncuCyte live-cell images of
ARPE-19 cells treated with DMSO-Control, 7kCh,
and 7kCh with epicatechin, respectively, are shown
in Figure 2G. 7kCh increased NucLight Red signal,
Caspase-3/7 green signal, and overlap signal
counts at 24 hours (Figure 2G, second row)
compared with DMSO-Control (Figure 2G, first row)
in ARPE-19 cells. These counts are reduced when
cultures are pretreated with inhibitors such as
epicatechin before exposure to 7kCh (Figure 2G,
third row).
Caspase-8 Inhibitor Z-IETD-FMK Reduces
Caspase-8 Activity in Only ARPE-19 Cells
ARPE-19 cells exposed to 7kCh had increased
caspase-8 activity (28,037 ± 398 msi, P < 0.001,
Figure 3A) compared to ARPE-19 cells exposed
only to DMSO (7,210 ± 478.8 msi, Figure 3A).
Caspase-8 activity in 7kCh exposed ARPE-19
cells was significantly reduced at 68.1% following
pretreatment with Z-IETD-FMK (8,952 ± 283 msi, P
< 0.01, Figure 3A). R28 cells exposed to 7kCh had
increased caspase-8 activity (34,734± 944.5msi, P
= 0.001, Figure 3B) compared to R28 cells exposed
only to DMSO (11,043 ± 55.5 msi, Figure 3B).
Caspase-8 activity in 7kCh-exposed R28 cells was
not significantly reduced at 8.4% by pretreatment
with Z-IETD-FMK (31,825 ± 3,073, P > 0.05, Figure
3B).
Caspase-12 Inhibitor Z-ATAD-FMK Reduces
Caspase-12 Activity in Only ARPE-19 Cells
ARPE-19 cells exposed to 7kCh had increased
caspase-12 activity (38,585 ± 1,804 msi, P < 0.001,
Figure 3C) compared to ARPE-19 cells exposed
only to DMSO (15,351 ± 636.5 msi, Figure 3C).
Caspase-12 activity in 7kCh-exposed ARPE-19 cells
was significantly reduced at 47.7% by pretreatment
with Z-ATAD-FMK (20,175 ± 719 msi, P = 0.001,
Figure 3C). R28 cells exposed to 7kCh had an
increased caspase-12 activity (31,234 ± 4,445 msi,
P < 0.05, Figure 3D) compared to R28 cells
exposed only to DMSO (10,043 ± 944.5 msi,
Figure 3D). Caspase-12 activity in 7kCh-exposed
R28 cells was not significantly reduced at 9.1% by
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Figure 2. Caspase-3/7 activity in 7kCh-treated ARPE-19 and R28 cells after pretreatment with memantine, simvastatin, or
epicatechin.
All cells exposed to 7kCh alone increased caspase-3/7 activity (A–F). Pretreatment of ARPE-19 cells with 1 µM** and 1 mM***
memantine (A) 0.01 µM*** and 0.05 µM*** simvastatin (C), or 5 µM epicatechin* (E) showed decreased caspase-3/7 activity. In
contrast, R28 cells pretreated with 1 µM and 1 mM memantine (B) 0.01 µM and 0.05 µM simvastatin (D), or 5 µM epicatechin
(F) did not have significantly decreased caspase-3/7 activity. Representative IncuCyte live-cell images of DMSO-Control, 7kCh,
and 7kCh with epicatechin-treated ARPE-19 cells at 24 hours (G). There are no major differences among treatments detected
with brightfield microscopy (G, first column). ARPE-19 cells stressed with 7kCh demonstrate increased nuclear staining number,
increased caspase-3/7 signal number, and an increased overlap signal number (G, second row). These counts decrease when
ARPE-19 cells are pretreated with epicatechin before 7kCh (G, third row).
*P < 0.05, **P < 0.01, ***P < 0.001. The error bars represent the standard error of the mean (SEM) of measurements for the four
conditions in three separate runs (n = 12, A–D) and three conditions in three separate runs (n = 9, E–F). Scale bar = 400 μM (G).
pretreatment with Z-ATAD-FMK (28,379± 4518msi,
P > 0.05, Figure 3D).
DISCUSSION
This study emphasized 7kCh’s role in caspase
activation and highlighted several clinical
drugs that protected RPE cells but not
R28 cells from 7kCh-induced apoptosis.
Research in the past two decades has
strongly supported 7kCh’s role in AMD
pathogenesis. 7kCh from LDL is esterified via
two enzymes, cPLA2α and SOAT1, to 7kCh-
fatty acid esters (7KFAEs), and effluxed by
HDL to the liver for bile acid production.[27]
Cholesterol levels may therefore contribute
to ocular disease as high serum levels of
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Figure 3. Caspase-8 and -12 activity in 7kCh-treated ARPE-19 and R28 cells in response to 7kCh alone or pretreatment with Z-
IETD-FMK or Z-ATAD-FMK.
All cells exposed to 7kCh alone showed increased caspase-3/7 activity (A–F). ARPE-19 cells pretreated with Z-IETD-FMK** (A) or
Z-ATAD-FMK** (C) showed decreased caspase-8 and -12 activity, respectively. In contrast, R28 cells pretreated with Z-IETD-FMK
(B) or Z-ATAD-FMK (D) did not show decreased caspase-8 nor -12 activities, respectively.
*p < 0.05, **p < 0.01, ***p < 0.001. The error bars represent the standard error of the mean (SEM) of measurements for the three
conditions in three separate runs (n = 9, A–D).
LDL or 7KFAEs (which revert to 7kCh), or low
levels of HDL can result in increased 7kCh
levels.[27] 7kCh may also accumulate over
time from natural mechanisms such as the
rhodopsin cycle and other photo-oxidative
processes.[28] Compared to controls, 7kCh
was found at 6- to 50-fold higher levels in
RPE and photoreceptor inner segments of
photodamaged rat retinas,[9] and at 4-fold levels
in Bruch’s membrane and neuroretinal cells in
photodamaged monkey retinas.[14, 28] Excess
7kCh can trigger caspase pathways, excess
reactive oxygen species (ROS) production,
endothelial dysfunction, breaks in Bruch’s
membrane, induction of cytokines IL-6 and
IL-8, and neovascularization in the choroid
[16–20, 29–31], which are all consistent with AMD.
Additional damage includes increased levels
of DNA fragmentation and increased chromatin
condensation in both ARPE-19 and R28 cells.[32]
7kCh also damages mitochondria by inducing
reactive oxygen/nitrogen species, reducing the
mitochondrial membrane potential by 2.2-fold (P
< 0.001), and decreasing levels of intact 16.2-kb
mtDNA.[16]
The clinically available inhibitors used in this
study all prevented 7kCh induced caspase-3/7
activation in ARPE-19 cells but not R28 cells:
(1) Memantine is a moderate-affinity,
noncompetitive antagonist of the glutamatergic
N-methyl-D-aspartate (NMDA) receptors. It
suppresses glutamate-excitotoxicity in animal
models associated with neurological diseases
such as Alzheimer’s, vascular dementia, and
retinal ganglion cell death after ischemic
strokes.[33–37] By inhibiting downstream p53
and calpain-caspase-3, it reduces Ca2+-dependent
production of NO and O2(–) and halts neuronal
apoptosis in rats with middle cerebral artery
occlusion.[36, 38, 39] A previous study showed
that memantine reduces caspase-3/7 activity
in staurosporine-treated neuronal cells.[40]
The present study showed 1 μM and 1 mM of
memantine reduced caspase-3/7 activity by
47.8% and 81.9% in ARPE-19 cells, respectively,
but only 5.9% and 4.5% in R28 cells (Figures
2A–2B) despite evidence of immunoreactivity
to NMDA and GABAa receptors.[41] This may
be because memantine can upregulate brain-
derived neurotrophic factor through the PI3-K/Akt
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pathway independent of NMDA receptors.[42]
Furthermore, R28 cells derived from six-day old
rat retina are not fully differentiated and may
not have well-developed NMDA receptors. R28
cultures are also heterogeneous and memantine
may preferentially affect neural cells with NMDA
receptors over non-neural glial cells.[23]
(2) Simvastatin is a hydrophobic drug that
inhibits 3-Hydroxy-3-methyl-glytaryl coenzyme
A (HMG-CoA) reductase and is frequently
utilized to reduce serum LDL in hyperlipidemic
patients.[43] Besides its lipid-lowering effects, it
is also neuroprotective and upregulates Bcl-2,
a major cell survival protein,[44, 45] and induces
Hsp27, a heat shock protein that promotes retinal
ganglion cell survival.[46] In rats with streptozotocin-
induced diabetes, therapeutic levels of simvastatin
slowed progression of diabetic retinopathy by
reducing VEGF activation, vascular permeability,
and endothelial-leukocyte adherence.[47] The
effects of statins are notably biphasic: low
concentrations of statins are pro-angiogenic,
while high concentrations are angiostatic.[48–50]
Higher concentrations can also induce caspase-
3/7 apoptosis in human monocytes, pericytes, and
tumor cells.[50–52] Our results show that 0.01 μM
and 0.05 μM of simvastatin reduced caspase-3/7
activity by 85.3% and 84.8%, respectively, in ARPE-
19 cells (Figure 2C), while 0.05 μM simvastatin
increased caspase activity by 17.5% in R28 cells
(Figure 2D). The therapeutic dose in ARPE-19 cells
was toxic in R28 cells, suggesting underdeveloped
drug import/export systems or excess HMG-CoA
reductase concentrations in R28 cells, but further
studies are needed.
(3) Epicatechin is a powerful antioxidant flavanol
found in many plant-based foods such as grapes,
dark chocolate, and green tea. It is commonly
used to reduce oxidative damage by inhibiting
nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase and maintaining nitric oxide (NO)
synthase, which prevents oxidized LDL endothelial
dysfunction implicated in dementia.[53–55] It can
also decrease levels ROS in the hippocampus of
rat models with hypertension and Alzheimer’s.[56]
Other studies show that epigallocatechin gallate, a
derivative with phenolic hydroxyl, injected into rat
retinas attenuated sodium nitroprusside-induced
oxidative stress in retinal ganglion cells.[57] Our
results show that epicatechin significantly reduced
caspase-3/7 activity by 83.6% in ARPE-19 cells, but
only 25.7% in R28 cells (P = 0.05. Figures 2E—
2F). Unlike the first two inhibitors, epicatechin’s
borderline p-value suggests it protects R28 cells
by decreasing general oxidative burden. Thus,
targeting upstream ROS production via NADPH
oxidasemay protect multiple retinal cell typesmore
effectively than targeting specific downstream
enzymes or receptors. These results are consistent
with those obtained by IncuCyte® Live-Cell Imaging
Analysis which captures caspase-3/7-mediated
apoptosis in real-time images (Figure 2G). The
overlapped signal (Figure 2G, fourth column)
shows increased caspase activity with 7kCh
(Figure 2G, second row) that was reduced with
epicatechin pretreatment (Figure 2G, third row).
Figure 2G shows the representative images of
ARPE-19 cells treated with DMSO-control (first
row), 7kCh (second row), and pretreated with
epicatechin (third row). Similar image results
were obtained with ARPE-19 cells pretreated with
simvastatin or memantine.
(4) Z-VAD-FMK is a direct pan-caspase inhibitor
that irreversibly binds the catalytic site of various
caspase proteases. It prevented cell shrinkage
and DNA fragmentation due to caspase-2, -3, -6,
and -8 in flounder immune cells,[58] and prevented
increases in p53, PARP-1, and caspase-3 levels
after 35 hours of glucose deprivation in retinal
ganglion cells.[59] In ARPE-19 cells, the Z-VAD-
FMK reduced 7-kCh-induced caspase-3/7 activity
by 48.0% but did not protect R28 (12.3%).
(5) Z-IETD-FMK is a direct caspase-8 inhibitor
that disrupts the extrinsic caspase pathway. It
reduced caspase-8 activity by 68.1% in ARPE-19
cells but had no protective effects in neuroretinal
cells (8.4%).
(6) Z-ATAD-FMK is a caspase-12 inhibitor that
disrupts the endoplasmic reticulum stress-induced
caspase pathway. In ARPE-19 cells, it reduced
caspase-12 activity by 47.7%. In contrast, there was
no significant effect on R28 cells, with only 9.1%
decrease in caspase activity.
Previous studies demonstrated that a
component of cigarette smoke, benzo(e)pyrene
[B(e)P], also induces caspase-3/7 activity in ARPE-
19 cells and was inhibited by genistein, resveratrol,
and memantine but not calpain, BTIC, simvastatin,
or epicatechin.[60] When combined with the current
study’s results, memantine could reverse both
B(e)P- and 7kCh-induced caspase-3/7 activities in
ARPE-19 cells, but simvastatin and epicatechin only
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reversed activity induced by 7kCh not B(e)P. This
indicates that the same cell type can have distinct
pathways to activate and inhibit caspase-3/7,
depending on the insult.
Likewise, the current study suggests that
different cell types have distinct pathways
to activate and inhibit apoptosis induced by
7kCh. None of the drugs significantly reduced
caspase activity in R28 cells, which strongly
implies that tissue characteristics or processes
maintain apoptosis in the presence of inhibitors.
As mentioned previously, R28 cells are retinal
precursor cells from six-day old rats that express
genes and proteins specific to their developmental
age, which may not include receptors that
respond to the drugs.[41] Furthermore, this
heterogeneous population has cell types with
distinct morphologies, biochemical characteristics,
and neuronal-specific cell markers. A subset of
R28 cells have receptors to neurotransmitters
such as dopamine, serotonin, glycine, and
acetylcholine; other cells have receptors that
respond to NMDA and GABA agonists; still
others show immunoreactivity to GluR1, GluR2,
and GluR3.[24, 41] In contrast, ARPE-19 cells are a
homogeneous population of RPE cells that grow
in a monolayer, express the same receptors and
RPE-selective markers like CRALBP, and have the
same cobblestone morphology.[61] Thus, receptor-
or enzyme-specific drugs such as the caspase
inhibitors, memantine, or simvastatin will affect all
ARPE-19 cells equally and the global response
is additive (–47.7% to –85.3% change in caspase
activity, all p-values < 0.05). In contrast, only
a fraction of R28 cells that express the target
enzyme or receptor will be affected, and the global
response is represented only by the subset (+17.5%
to –25.7% change in caspase activity, all p-values
> 0.05).
In summary, the current study quantified
caspase-3/7 activity as a marker of apoptosis
between human ARPE-19 cells and rat R28 cells
after treatment with 7kCh and various inhibitors.
7kCh significantly induced caspase-3/7 for both
cultures, yet pretreatment with anti-apoptotic drugs
(memantine, simvastatin, epicatechin, Z-VAD-FMK,
etc.) consistently reduced caspase activities only
in the ARPE-19 cells. This discrepancy in caspase
deactivation between ARPE-19 and R28 cells may
be related to the differences in the heterogeneity
of the cell population or the age and species of
the original tissue. Ultimately, the etiology of AMD
is multifactorial and future treatments may utilize
combination therapy to inhibit common toxins,
like 7kCh and B(e)P, that affect multiple retinal cell
targets.
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